Pfizer says antiviral COVID-19 pill cuts risk of severe disease by 89% in high-risk adults

Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90 per cent in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.

from CBC | Health News https://ift.tt/3o0Tg5Z